For: | Dahiya DS, Perisetti A, Kichloo A, Singh A, Goyal H, Rotundo L, Vennikandam M, Shaka H, Singh G, Singh J, Pisipati S, Al-Haddad M, Sanaka MR, Inamdar S. Increasing thirty-day readmissions of Crohn’s disease and ulcerative colitis in the United States: A national dilemma. World J Gastrointest Pathophysiol 2022; 13(3): 85-95 [PMID: 35720163 DOI: 10.4291/wjgp.v13.i3.85] |
---|---|
URL: | https://www.wjgnet.com/2150-5330/full/v13/i3/85.htm |
Number | Citing Articles |
1 |
Saleha Aziz, Anum Akhlaq, Anna Owings, Sana Gurz, Yousaf Zafar, Basim Ali, Shou-jiang Tang. Mortality Trends in Inflammatory Bowel Disease by Age, Sex, and Race in the United States from 1999 to 2020. Inflammatory Bowel Diseases 2024; doi: 10.1093/ibd/izae184
|
2 |
Yorinobu Maeda, Yuta Goto, Fumiya Ohnishi, Syoutarou Koga, Satoshi Kawano, Yuhzo Hieda, Takeshi Goromaru, Teruo Murakami. 5-Aminosalicylic Acid Distribution into the Intestinal Membrane Along the Gastrointestinal Tract After Oral Administration in Rats. Pharmaceutics 2024; 16(12): 1567 doi: 10.3390/pharmaceutics16121567
|
3 |
Phi Tran, Matthew Tjahja, Yilun Wang, Nikhil Seth, Rylyn Reyes, Charles Bussell, Audrene Edwards, Christopher M. Johnson. Close outpatient follow-up associated with reduced readmission rates in patients with inflammatory bowel disease. Baylor University Medical Center Proceedings 2024; 37(4): 517 doi: 10.1080/08998280.2024.2335095
|
4 |
Grant E Barber, Justin Zhuo, Philip N Okafor, Sarah Streett. Gastroenterology Clinic Follow-Up Reduces Gastroenterology-Specific Readmissions Among Patients With Severe Ulcerative Colitis. Inflammatory Bowel Diseases 2024; 30(8): 1319 doi: 10.1093/ibd/izad207
|
5 |
Irēna Teterina, Veronika Mirzajanova, Viktorija Mokricka, Maksims Zolovs, Dins Šmits, Juris Pokrotnieks. National 30-Day Readmission Trends in IBD 2014–2020—Are We Aiming for Improvement?. Medicina 2024; 60(8): 1310 doi: 10.3390/medicina60081310
|